Navigation Links
Local School Nurses Unite Community to Combat Low Meningitis Vaccination Rates Among Preteens and Teens in San Diego
Date:9/28/2011

t the dangers of meningococcal meningitis and the importance of prevention for preteen and teenage children.  

Voices of Meningitis includes educational materials for the public and health-care providers, as well as a public service campaign featuring school nurses, disease survivors, and families affected by meningitis. The campaign also features a comprehensive website, www.VoicesOfMeningitis.org, where visitors can hear the compelling stories of families that have been personally affected by meningitis and access educational information about the disease and the importance of vaccination.  The campaign also includes a Facebook page, Raise Your Voice Against Meningitis, where users can learn about the disease and pledge to vaccinate their children.

Voices of Meningitis is a program of the National Association of School Nurses in collaboration with Sanofi Pasteur, the vaccines division of Sanofi-Aventis Group.

About Meningococcal Disease

Meningococcal disease is a serious infection that can cause meningitis (swelling of the brain or spinal cord) or meningococcemia (blood infection). The disease can be spread through common everyday activities, such as sharing drinking glasses, living in close quarters like dormitories, and kissing. Meningococcal disease can be hard to recognize, especially in its early stages, because symptoms are similar to those of more common viral illnesses.  Unlike more common illnesses, the disease can progress quickly and may cause death or disability in just a single day. In the United States, about 10 percent of the 1000 to 2600 Americans who get meningitis each year will die. For survivors, one in five is left with serious medical problems, including amputation of limbs, brain damage, deafness and organ damage.

Public health officials recommend meningococcal vaccination for preteens and teens beginning at age 11,
'/>"/>

SOURCE National Association of School Nurses
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
2. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery
5. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
6. On World AIDS Day, CHF International Calls for Community Mobilization and Local Capacity Building to Fight HIV/AIDS
7. New Localized Cancer Treatment for Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision in Some Cases
8. Banner Alzheimers Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
9. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
10. Journal of the American Dental Association Publishes Key Clinical Data for the Use of OraVerse(TM) a Local Anesthetic Reversal Agent
11. High Intensity Focused Ultrasound for Locally Recurrent Prostate Cancer Following External Beam Radiation Therapy Investigated in Phase III Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015  Amgen (NASDAQ: AMGN ... quarter of 2015. Key results include: , ... quarter of 2014 to $5,370 million, with 6 ... ® (etanercept), Prolia ® (denosumab), Sensipar ... XGEVA ® (denosumab). Unfavorable changes in foreign ...
(Date:7/30/2015)...  Amgen (NASDAQ: AMGN ) today announced the appointment ... Warburg Pincus LLC, to the Amgen Board of Directors. ... and the deep, global experience he brings in the ... Bradway , chairman and chief executive officer of Amgen. "Fred,s breadth ... well." Mr. Hassan has been Partner and Managing ...
(Date:7/30/2015)... CHAGRIN FALLS, Ohio , July 30, 2015 /PRNewswire/ ... in his OMTEC® 2015 keynote address last month that ... business models in order to gain the efficiencies—and develop ... future. Dr. Barsoum,s comments were preceded by ... Tornier, avid entrepreneur and OMTEC moderator, who stressed that ...
Breaking Medicine Technology:Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2
... (NASDAQ: ARNA ) announced today that ... JMP Securities Healthcare Conference on Tuesday, September 27, 2011, at ... St. Regis New York Hotel in New York City. Jack ... provide a corporate overview. A live audio webcast ...
... Group, Inc.  (OTCBB: MDXG), an integrated developer, manufacturer ... bioimplants processed from human amniotic membrane, announced today ... national, leading distributor of spine, biologic and other ... Administration ("VA") and Department of Defense ("DOD") facilities. ...
Cached Medicine Technology:Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference 2Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference 3MiMedx Group Partners With Affirmative Solutions 2MiMedx Group Partners With Affirmative Solutions 3
(Date:8/2/2015)... ... ... A new Phase I research study is looking at a vaccine that hopes ... G. Lucas, M.D. , chief of the division of pediatric hematology/oncology and stem cell ... Hospital and in the UofL Department of Pediatrics . Patients are currently ...
(Date:8/2/2015)... ... August 03, 2015 , ... For many “would be” entrepreneurs, starting a new business can ... can’t afford to start a business.” Neither needs be a major obstacle. , The ... to start a business and be successful. The risks of starting a business can be ...
(Date:8/2/2015)... (PRWEB) , ... August 02, ... ... results when the supportive muscles and connective tissues of a woman’s pelvic ... weakness and damage include straining, heavy lifting, obesity, constipation, multiple vaginal deliveries, ...
(Date:8/2/2015)... ... August 02, 2015 , ... Molecular biologists in New South Wales ... mesothelioma. Surviving Mesothelioma has just posted an article on the new research. Click ... Wales tested for Ki67 expression in tissue samples from 42 patients with peritoneal mesothelioma ...
(Date:8/1/2015)... ... August 02, 2015 , ... AlignLife Office Coordinator Heather ... continuity of care for patients at this natural health care center in Winamac. , ... Mary Heal said. "Heather's role is vital to our approach because we want to ...
Breaking Medicine News(10 mins):Health News:UofL Physicians Conducting Vaccine Trial for Children with Relapsed Tumors at Kosair Children’s Hospital 2Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 2Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 3Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 4Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 5Health News:Minimally Invasive and Robotic Treatment for Pelvic Organ Prolapse Now Available from the Specialists at Women’s Excellence in Bladder Control 2Health News:Scientists Link Protein Marker with Mesothelioma Prognosis in New Study, According to Surviving Mesothelioma 2Health News:New Patient Advocate Enhances Natural Health Care 2
... of UCSF scientists have received grants from the California ... based strategies for treating diabetes and brain tumors. ... file new drug applications to the U.S. Food and ... clinical trials. The two grants, awarded to collaborative ...
... have DNA that may make things tougher behind the wheel, researchers ... bad driver? Maybe you can blame it on your genes. , ... variation performed 20 percent worse on simulated driving tests and did ... have the variation, the team said. , "These people make more ...
... ... be used to establish the Meharry Clinical and Translational Research Center (MeTRC) to further health ... ... of the National Institutes of Health (NIH), announced today that it will provide $21.4 million ...
... to delays in the nationwide distribution H1N1 flu vaccine, Department ... steps to prevent the spread of illness. , "We ... H1N1 vaccine," Department of Health Deputy Secretary Michael Huff said ... and distribution. "We, too, are frustrated by the production delays. ...
... 29 Although women with chronic hepatitis C virus (HCV) ... compared outcomes for men and women after having liver transplantation ... graft loss and graft loss from recurrent HCV than men. ... HCV and higher risk of developing advanced HCV, our results ...
... energy to stimulate the body,s healing process, are promising ... a number of conditions, reducing anxiety for hospitalized patients ... what standard treatments can achieve. However, longer-term effects are ... of Cancer Prevention and Control Research, and Dr. Paul ...
Cached Medicine News:Health News:UCSF diabetes, brain tumor stem cell grants to drive development of therapies 2Health News:UCSF diabetes, brain tumor stem cell grants to drive development of therapies 3Health News:UCSF diabetes, brain tumor stem cell grants to drive development of therapies 4Health News:Is There a 'Bad Driver' Gene? 2Health News:Meharry Medical College Receives $21.4 Million NIH Research Grant, Largest in Its History 2Health News:Meharry Medical College Receives $21.4 Million NIH Research Grant, Largest in Its History 3Health News:PA Department of Health: National Delays in H1N1 Flu Vaccine Distribution Highlight Need for Continued Prevention Efforts 2Health News:Women Are at Greater Risk Than Men of Graft Loss After Undergoing Liver Transplantation for Hepatitis C-related Liver Disease 2Health News:Women Are at Greater Risk Than Men of Graft Loss After Undergoing Liver Transplantation for Hepatitis C-related Liver Disease 3Health News:Biofield therapies: Helpful or full of hype? 2
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... a 1-step, hand-held, point-of-care device for the qualitative ... urine. The TOX/See device can detect up ... in 3 to 8 minutes and requires only ... is individually packaged to maximize convenience and ease ...
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... from CTS pain and hand tingling in ... CTS treatments. It is not a rigid ... Solution gently reshapes soft tissue in and ... pain, numbness and sleep interruption. It allows ...
Medicine Products: